TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) Investor Investigation Over Potential Breaches Of Fiduciary Duties

  • If you purchased shares of Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) and currently hold any of those NASDAQ:OPTR shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

May 15, 2013 (Update) - On May 13, 2013, a media report stated that AstraZeneca plc and Cubist Pharmaceuticals reportedly made first round bids for Optimer Pharmaceuticals, Inc. Shares of Optimer Pharmaceuticals, Inc jumped from $13.415 on May 13, 2013, to $14.70 on May 14, 2013. Then on May 15, 2013, another media report cited two people familiar with the matter that said that Cub...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: